Skip to main content
. 2012 Nov 26;3:273. doi: 10.3389/fgene.2012.00273

FIGURE 1.

FIGURE 1

Highest-ranking barriers to implementing the use of pharmacogenomics testing, based on a survey of Spanish Societies for Pharmacology and Clinical Pharmacology members in 2012. Data related to average importance (on a scale of 1–10) are plotted along the x-axis.